Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 7 | 2025 | 443 | 1.040 |
Why?
|
| Thyroxine | 9 | 2019 | 388 | 0.720 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2025 | 162 | 0.630 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 215 | 0.540 |
Why?
|
| Pituitary Neoplasms | 2 | 2007 | 74 | 0.470 |
Why?
|
| Carcinoma, Papillary | 2 | 2018 | 161 | 0.470 |
Why?
|
| Adenoma | 2 | 2006 | 260 | 0.350 |
Why?
|
| Iodine Radioisotopes | 2 | 2001 | 138 | 0.340 |
Why?
|
| Thyroxine-Binding Proteins | 9 | 1992 | 86 | 0.340 |
Why?
|
| Thyroid Nodule | 2 | 2022 | 60 | 0.330 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2008 | 7 | 0.290 |
Why?
|
| Electronic Prescribing | 1 | 2008 | 10 | 0.280 |
Why?
|
| Medical Order Entry Systems | 1 | 2008 | 27 | 0.280 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 1094 | 0.280 |
Why?
|
| Medication Errors | 1 | 2008 | 38 | 0.280 |
Why?
|
| Safety Management | 1 | 2008 | 58 | 0.280 |
Why?
|
| Triiodothyronine | 9 | 2001 | 362 | 0.260 |
Why?
|
| Hyperprolactinemia | 1 | 2007 | 5 | 0.260 |
Why?
|
| Hyperthyroidism | 5 | 2001 | 76 | 0.260 |
Why?
|
| Prolactinoma | 1 | 2007 | 7 | 0.260 |
Why?
|
| Testosterone | 3 | 2007 | 277 | 0.260 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2008 | 123 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 231 | 0.250 |
Why?
|
| Thyrotropin | 7 | 1994 | 311 | 0.240 |
Why?
|
| Progestins | 1 | 2006 | 23 | 0.240 |
Why?
|
| Plasmacytoma | 1 | 2006 | 34 | 0.240 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2005 | 96 | 0.230 |
Why?
|
| Contraception | 1 | 2006 | 100 | 0.220 |
Why?
|
| Mutation | 4 | 2025 | 4374 | 0.220 |
Why?
|
| Bone Density | 1 | 2006 | 239 | 0.210 |
Why?
|
| Erectile Dysfunction | 1 | 2004 | 79 | 0.210 |
Why?
|
| Weight Loss | 1 | 2004 | 240 | 0.190 |
Why?
|
| Hypothyroidism | 5 | 2003 | 276 | 0.190 |
Why?
|
| Goiter, Nodular | 1 | 2001 | 7 | 0.180 |
Why?
|
| Parathyroid Neoplasms | 1 | 2001 | 60 | 0.170 |
Why?
|
| Thyroid Diseases | 3 | 1989 | 106 | 0.160 |
Why?
|
| Thyroid Hormones | 4 | 2003 | 352 | 0.150 |
Why?
|
| Humans | 33 | 2025 | 96105 | 0.150 |
Why?
|
| Endocrinology | 1 | 2020 | 50 | 0.150 |
Why?
|
| Prolactin | 2 | 2007 | 89 | 0.140 |
Why?
|
| Female | 19 | 2025 | 50028 | 0.140 |
Why?
|
| Obesity | 1 | 2004 | 1030 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2022 | 591 | 0.130 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2018 | 57 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 107 | 0.130 |
Why?
|
| Nuclear Reactors | 1 | 1996 | 7 | 0.120 |
Why?
|
| Radioactive Hazard Release | 1 | 1996 | 8 | 0.120 |
Why?
|
| Hyperostosis Frontalis Interna | 1 | 2014 | 3 | 0.110 |
Why?
|
| Adult | 16 | 2025 | 28721 | 0.110 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2014 | 71 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2022 | 108 | 0.100 |
Why?
|
| Male | 17 | 2025 | 45863 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1096 | 0.090 |
Why?
|
| Liver | 2 | 1988 | 1238 | 0.090 |
Why?
|
| Thyroid Function Tests | 3 | 1994 | 124 | 0.080 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1990 | 40 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 432 | 0.080 |
Why?
|
| Neoplasms | 1 | 2005 | 3248 | 0.080 |
Why?
|
| Hyperthyroxinemia | 1 | 1988 | 17 | 0.070 |
Why?
|
| Medication Systems, Hospital | 1 | 2008 | 7 | 0.070 |
Why?
|
| Thyroid Crisis | 1 | 1988 | 3 | 0.070 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1988 | 20 | 0.070 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 38 | 0.070 |
Why?
|
| Parathyroidectomy | 2 | 2014 | 79 | 0.070 |
Why?
|
| Documentation | 1 | 2008 | 103 | 0.070 |
Why?
|
| Middle Aged | 9 | 2025 | 28368 | 0.070 |
Why?
|
| Ergolines | 1 | 2007 | 8 | 0.060 |
Why?
|
| Bromocriptine | 1 | 2007 | 12 | 0.060 |
Why?
|
| Dopamine Agonists | 1 | 2007 | 27 | 0.060 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2006 | 23 | 0.060 |
Why?
|
| Drug Implants | 1 | 2006 | 40 | 0.060 |
Why?
|
| Diabetes Insipidus | 1 | 2006 | 17 | 0.060 |
Why?
|
| Bone Resorption | 1 | 2006 | 45 | 0.060 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2006 | 12 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 117 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1619 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2005 | 236 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 1995 | 160 | 0.050 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 2 | 1995 | 118 | 0.050 |
Why?
|
| Blood Protein Disorders | 1 | 1983 | 8 | 0.050 |
Why?
|
| Alpha-Globulins | 1 | 1983 | 11 | 0.050 |
Why?
|
| Thyroglobulin | 1 | 1983 | 59 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2005 | 339 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2005 | 744 | 0.050 |
Why?
|
| Aged | 6 | 2025 | 20968 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 1973 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2003 | 97 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2025 | 10287 | 0.040 |
Why?
|
| Antithyroid Agents | 1 | 2001 | 23 | 0.040 |
Why?
|
| Disease Progression | 1 | 2005 | 1562 | 0.040 |
Why?
|
| Age Factors | 1 | 2005 | 1963 | 0.040 |
Why?
|
| Physicians | 1 | 2008 | 707 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 1349 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2001 | 173 | 0.040 |
Why?
|
| Adolescent | 4 | 2006 | 9895 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2001 | 688 | 0.040 |
Why?
|
| Radioimmunoassay | 3 | 1989 | 150 | 0.040 |
Why?
|
| Drug Resistance | 2 | 1990 | 237 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2025 | 1471 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2014 | 9175 | 0.030 |
Why?
|
| Health Policy | 1 | 2020 | 208 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 82 | 0.030 |
Why?
|
| Ukraine | 1 | 1996 | 22 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 514 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1996 | 192 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 271 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 644 | 0.030 |
Why?
|
| Oncogenes | 1 | 1996 | 100 | 0.030 |
Why?
|
| Reference Values | 2 | 1988 | 674 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 1996 | 176 | 0.030 |
Why?
|
| Surgeons | 1 | 2020 | 298 | 0.030 |
Why?
|
| Risk Factors | 1 | 2005 | 5961 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3639 | 0.030 |
Why?
|
| Child, Preschool | 3 | 1995 | 3974 | 0.030 |
Why?
|
| Thymectomy | 1 | 2014 | 32 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2006 | 2591 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2014 | 71 | 0.030 |
Why?
|
| Cell Line | 3 | 1988 | 2537 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1876 | 0.030 |
Why?
|
| Proline | 1 | 1994 | 56 | 0.030 |
Why?
|
| Serine | 1 | 1994 | 108 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 228 | 0.020 |
Why?
|
| Point Mutation | 1 | 1994 | 247 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1667 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 7025 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1988 | 426 | 0.020 |
Why?
|
| Child | 4 | 1995 | 7625 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2860 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2014 | 364 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1276 | 0.020 |
Why?
|
| Pedigree | 2 | 1994 | 982 | 0.020 |
Why?
|
| United States | 2 | 2020 | 7768 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 1988 | 793 | 0.020 |
Why?
|
| Thyrotoxicosis | 1 | 1988 | 18 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 1989 | 38 | 0.020 |
Why?
|
| Immunoassay | 1 | 1989 | 100 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 873 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1979 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1988 | 128 | 0.020 |
Why?
|
| Animals | 3 | 2001 | 28891 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1988 | 599 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3927 | 0.020 |
Why?
|
| Estradiol | 1 | 1988 | 255 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2480 | 0.020 |
Why?
|
| Base Sequence | 3 | 1995 | 2344 | 0.020 |
Why?
|
| Dialysis | 1 | 1985 | 24 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1992 | 1423 | 0.010 |
Why?
|
| Rats | 2 | 1989 | 4155 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 3040 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2777 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1989 | 1805 | 0.010 |
Why?
|
| Infant | 1 | 1990 | 3363 | 0.010 |
Why?
|
| X Chromosome | 1 | 1983 | 157 | 0.010 |
Why?
|
| Heterozygote | 1 | 1983 | 382 | 0.010 |
Why?
|
| Protein Denaturation | 3 | 1988 | 109 | 0.010 |
Why?
|
| Hot Temperature | 3 | 1988 | 217 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 7229 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 39 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1995 | 147 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1995 | 180 | 0.010 |
Why?
|
| Introns | 1 | 1992 | 304 | 0.010 |
Why?
|
| Exons | 1 | 1992 | 454 | 0.010 |
Why?
|
| Genotype | 1 | 1994 | 1881 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2090 | 0.000 |
Why?
|
| Phenolsulfonphthalein | 1 | 1988 | 3 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1988 | 50 | 0.000 |
Why?
|
| Blood | 1 | 1988 | 69 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 311 | 0.000 |
Why?
|
| DNA | 1 | 1994 | 1333 | 0.000 |
Why?
|
| Phenotype | 1 | 1994 | 2578 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 1049 | 0.000 |
Why?
|
| Receptors, Estrogen | 1 | 1988 | 417 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1988 | 623 | 0.000 |
Why?
|
| Isoelectric Focusing | 1 | 1985 | 29 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1985 | 18 | 0.000 |
Why?
|
| Myocardial Contraction | 1 | 1986 | 253 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 270 | 0.000 |
Why?
|
| Heart Rate | 1 | 1986 | 518 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1986 | 531 | 0.000 |
Why?
|
| Kinetics | 1 | 1985 | 1562 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1988 | 2090 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1986 | 810 | 0.000 |
Why?
|
| Pregnancy | 1 | 1988 | 3240 | 0.000 |
Why?
|